1 dr mughals vitamin d talk [read-only] dr mughals vitamin d talk.pdf · vitamin d zulf mughal...
TRANSCRIPT
Vitamin D
Zulf Mughal
Consultant in Paediatric Bone Disorders
Department of Paediatric Endocriology
Royal Manchester Children's Hospital
Manchester
M13 0JH
Bone Study Day, 28th September 2012
Overview
� Sources & Metabolism of Vitamin D
� Musculoskeletal consequences of Vitamin D deficiency
� Non-musculoskeletal associations of Vitamin D deficiency
� The Criteria or Definition of Vitamin D deficiency
� Prevention of Vitamin D deficiency
Sources & Metabolism of Vitamin D
Solar UVB (280-310nm)
Endogenous Vitamin D3
Dietary sourceVitamin D2 & D3
Oily fish, eggs,
fortified foods e.g:
� Infant formulas
� Cereals
Liver
25-Hydroxyvitamin D
(major circulating metabolite)
1,25-Dihydroxyvitamin D
Kidney
1α hydroxylase
(CYP27B1)
� PTH (+)
� ↓ P (+)
� FGF23 (-)
(7-dehydoxycholesterol)
DBP
25-hydroxylase
(CYP2R1)
24-hydroxylase
(CYP24A1)
DBP
24,25-hydroxyvitamin D
Calcitroic acid
Normal Growth Plate Rachitic Growth Plate
Low Calcium
or
Low Phosphorous
Radiograph showing
Rachitic Changes
Factors which contribute to development of Vitamin D deficiency
� Residence in Northern or Southern Latitudes
� Pigmented skin
� Sun blocking creams – Factor 8 ↓ Vit D synthesis by >95%
� Sunshine avoidance for religious or cultural reasons
� Cloud Cover & Atmospheric Pollution
� Obesity
� Genetic propensity
� An independent protective effect of meat consumption
� Low dietary Calcium & High Fibre diets
Ethnicity
Asians
Caucasians
Maternal 25(OH)D(ng/ml)
6050403020100
Cord 25(OH)D(ng/ml)
50
40
30
20
10
0
R=0.98 (p<0.001)
Maternal & Cord 25-Hydroxyvitamin D Concentrations
Vitamin D stores acquired during fetal life last ~ 8 weeks
Lau 2001 (Unpublished)
N = 22
15 South Asians
109 Whites
Farrar et al Am J Clin Nutr. 2011;94(5):1219-24.
Serum 25(OH) Levels after Simulated Summer Sunlight Exposures
in Whites & South Asians
Definition of vitamin D deficiency & sufficiency based on serum 25(OH)D
concentrations
Vitamin D Deficiency & Insufficiency
Davies JH & Shaw NJ. Arch Dis Child. 2010 Jul 23. [Epub ahead of print]
Pune (18.340N)
N = 50
Manchester (54.40N)
N=51
Age (years) 14.7 ± 0.7 15.3 ± 0.4
Serum 25OHD concentrations < 12 ng/ml 70% 73%
PTH > upper end of the reference range 48% 6%
Serum calcium concentration < 2.2 mmol/l (%) 74% 0%
Non-specific aches and pains (%) 76% 26%
Genu Varum or Genu Valgum (%) 44% 0%
Dietary vitamin D intake (µg/day) 0.17 1.3
% Ca intake (mg/day) - dairy products 65 (31-76) 401 (195 - 594)
Total Ca intake (mg/day) 449 (356 - 538) Data not available
Khadilkar, Das, Sayyad, Sanwalka, Bhandari, Khadilkar, Mughal. Low Calcium intake & Hypovitaminosis D in Adolescent
Girls. Archives of Disease in Childhood. 2007 ;92(11):1045
Low Calcium Diet & Vitamin D Deficiency
Low Calcium & High Fibre Diet and Vitamin D Status
Vitamin D Dietary Ca
� High fibre & phytic acid reduce dietary Ca intake
� Low Ca intake leads to secondary hyperparathyroidism & raised serum
1,25(OH)2D concentration
� Raised serum 1,25(OH)2D concentration degrades 25OHD to inactive
24,25-dihydroxyvitamin D, thereby depleting body stores of vitamin D
Clements et al. Nature 1987;325:62–5
DIETARY CALCIUM INTAKE
1 ml ~ 1mg
1 pot ~ 150 mg
~ 35 mg/slice
1 Bowl ~ 80 mg
1 oz ~ 200 mg
RNI (mg/day) in the UK
Infants up to 1 yr 525
Children 1- 3 yrs 350
Children 2-6 yrs 450
Children 7-10 yrs 550
Adolescent boys 11-18 yrs 1000
Adolescent girls 11-18 yrs 800
DIAGNOSIS: Severe vitamin D deficiency & low calcium intake
Pre Rx Post Rx
25(OH)D (ng/ml) <2 27.1
PTH (ng/ml)
(10-60)
593 90
Calcium (mmol/l)
(2.15 – 2.65)
1.38 2.23
Phosphate (mmol/l)
(1.0 – 1.8)
1.68 1.43
Alk Phos (I/U) 1020 592
Rx: Single orally dose 180, 000 IU Vitamin D3 + 500mg/day Ca supplement
Vitamin D Deficiency & MyopathyVitamin D Deficiency & Myopathy
� 14 year old female
� Limb pains
� Difficulty walking & Climbing stairs
� Life long intolerance of dairy products
(Ca intake <300 mg/day)
� Arrived from Saudi Arabia 8 months
ago
8th April 09 5th May 09
Life threatening Cardiomyopathy in Early Infancy
Maiya S et al .Hypocalcaemia and Vitamin D deficiency: an important, but preventable cause of
life threatening infant heart failure.Heart. 2007 Aug 9; [Epub]
� 16 infants (6 South Asian, 10 Black ethnicity) admitted to GOS with Heart Failure
� Median age 5.3 months (3 weeks - 8 months);12 exclusively breast-fed
� 12 needed inotropic support
� 8 ventilated & 2 needed ECMO
� 2 referred for cardiac transplantation
� 6 suffered a cardiac arrest & 3 died!
Median (range) Reference range
Calcium (mmol/L) 1.50 (1.07 – 1.74) 2.17 – 2.44
PTH (pmol/L) 34.3 (8.9 – 102) 0.7 – 5.6
25OHD (nmol/L) 18.5 (0.00 – 46) >50
Fractional shortening (%) 10 (5-18) 28 – 45
Left ventricular end diastolic
dimension Z score 4.1 (3.1-7) -2 < +2
Vitamin D & Innate Immunity
Adequate serum 25(OH)D
Innate immunity
� Toll like receptors recognise pathogens
�
� � expression of VDR & CYP27B1 enzyme
25(OH)D � 1,25(OH)2D
� 1,25(HO)2D leads to production of
antimicrobial proteins (AMPs)
� AMPs (e.g. Cathelcidin) important role in
defence against bacterial & viral infections
Proportion of children free of a repeat episode of pneumonia up to 90 days post-treatment
Rx of 1-36 month olds with 100,000 i.u.
Vitamin D3/Placebo + antibiotics
� DID NOT reduce the duration
of illness
(p=0.17)
� DID reduce readmission to
hospital with pneumonia
(p=0.01)
Manaseki-Holland S, Qader G, Masher M I, Bruce J. Mughal M Z, Chandramohan D, Walraven G,
Effects of Vitamin D supplementation to children diagnosed with pneumonia in Kabul: A
randomised controlled trial.
Tropical Medicine & International Health 2010;15 (10), 1148–1155
Effects of Vitamin D supplementation in children diagnosed
with pneumonia in Kabul: A randomised controlled trial
0.00
0.25
0.50
0.75
1.00
Proportion of children
204 162(37) 121(35) 0(15)Vitamin D211 156(52) 104(45) 0(19)Placebo
Number at risk (no of episodes)
0 30 60 90Time since recruitment (days)
Placebo
Vitamin D
Proportion of Children without First or Only Episode of X-Ray Confirmed Severe &
Non-Severe Pneumonia
� 3,406 infants randomised to
100,000 i.u. Vitamin D3 or Placebo
every 3-monthly, for 18 months
� Subjects visited fortnightly to
assess their health status
� Subjects with signs of pneumonia
had a chest radiograph to confirm
the diagnosis of pneumonia.
� No difference in the incidence of
pneumonia between the vitamin D
and the placebo group
Vitamin D Supplementation to Infants in Kabul had NO effect on the
incidence of Pneumonia: A randomised controlled trial
0.50
0.75
1.00
Proportion of children
1477 1375(88) 1252(82) 1199(14) 1169(9) 1099(39) 0(13)Placebo1485 1362(94) 1246(81) 1217(8) 1183(11) 1086(50) 0(16)Vitamin D
Number at risk (no of episodes)
0 90 180 270 360 450 540Time since recruitment (days)
Vitamin D
Placebo
Manaseki-Holland, Maroof, Bruce, Mughal, Masher, Bhutta, Walraven, Chandramohan Effect on the incidence of pneumonia of vitamin D
supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial LANCET .2012;14;379(9824):1419-27
Summary
� Subclinical vitamin D deficiency is very common in the UK
� Severe vitamin D deficiency is associated skeletal muscle weakness & cardiomyopathy.
� No clear definition of vitamin D deficiency based on serum 25(OH)D levels in children.
� Pragmatic lower limit of vitamin D sufficiency – 20 ng/ml or 50 nmol/l.
� Adequate dietary calcium intake is important in order to prevent vitamin D breakdown.
� Musculoskeletal symptoms of vitamin D deficiency are less likely to occur when dietary calcium intake is adequate & serum PTH is normal.
� Vitamin D deficiency may be associated with increased risk of infections, autoimmune disorders, respiratory diseases & certain cancers. RCTs needed to confirm these associations!